BCYC logo

Bicycle Therapeutics plc (BCYC)

Profile

Full Name

Bicycle Therapeutics plc

Ticker

NASDAQ: BCYC

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United Kingdom

IPO

May 23, 2019

Indexes

Not included

Website

https://www.bicycletherapeutics.com

Employees

305

Key Details

Price

$7.14(3.93%)

Market Cap

$495.29M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$35.29M(30.31% YoY)

Annual EPS

-$2.91(42.99% YoY)

PE Ratio

-

Next earnings date

Feb 24, 2026

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $7.14
    BCYC price is $7.14

    30-Day Relative Volume

    0.78
    BCYC 30-day relative volume is 0.78

    Price Performance

    Price Most Recent Change

    +3.93%
    BCYC price was up +3.93% on Dec 3, 2025

    Price YTD Change

    -49%
    BCYC price is down -49% since January 1st

    Price 1-Year Change

    -63.72%
    BCYC price is down -63.72% year-on-year

    Price 3-Year Change

    -77.5%
    BCYC price is down -77.5% over the past 3 years

    Price Range

    Price All-Time High

    $62.08
    BCYC price is currently -88.50% below its historical high of $62.08

    Price 3-Year Low

    $6.03
    BCYC price is currently +18.41% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $495.29M
    BCYC market cap is $495.29 million

    Market Cap 3-Year Change

    -47.42%
    BCYC market cap is down -47.42% over the past 3 years

    Market Cap All-Time High

    $1.90B
    BCYC market cap is currently -73.91% below its historical high of $1.90 billion

    Market Cap Sector Percentile

    61.75%
    BCYC market cap is higher than 61.75% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.47%
    BCYC shares outstanding is up +0.47% year-on-year

    Shares Outstanding 3-Year Change

    +133.64%
    BCYC shares outstanding is up +133.64% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.10
    BCYC beta is 1.10

    200-day SMA

    $8.04
    BCYC price is currently -11.21% below its 200-day simple moving average

    50-day SMA

    $7.50
    BCYC price is currently -4.75% below its 50-day simple moving average

    14-Day RSI

    51.76
    BCYC 14-day relative strength index is 51.76

    Volume

    0.78
    BCYC 30-day relative volume is 0.78

    ATR

    $0.47
    BCYC average true range is $0.47

    10-day Historical Volatility

    66.47%
    BCYC 10-day historical volatility is 66.47%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $35.29M
    BCYC annual revenue is $35.29 million

    Revenue Analysts Estimate

    $32.45M
    BCYC annual revenue is currently +8.77% higher than the consensus analysts' forecast

    Revenue 1-Year Change

    +30.31%
    BCYC annual revenue is up +30.31% year-on-year

    Revenue Sector Percentile

    58.5%
    BCYC annual revenue is higher than 58.5% of companies in Healthcare sector

    EPS

    EPS

    -$2.91
    BCYC annual earnings per share is -$2.91

    EPS Analysts Estimate

    -$3.88
    BCYC annual earnings per share is currently +25.08% higher than the consensus analysts' forecast

    EPS 1-Year Change

    +42.99%
    BCYC annual earnings per share is up +42.99% year-on-year

    EPS Sector Percentile

    31.15%
    BCYC annual earnings per share is higher than 31.15% of companies in Healthcare sector

    Profit

    Gross Profit

    $28.11M
    BCYC annual gross profit is $28.11 million

    Gross Margin

    79.66%
    BCYC annual gross profit margin is 79.66%

    Operating Profit

    -$252.47M
    BCYC annual operating income is -$252.47 million

    Operating Margin

    -715.41%
    BCYC annual operating profit margin is -715.41%

    Net Income

    -$169.10M
    BCYC annual net profit is -$169.10 million

    Net Margin

    -479.18%
    BCYC annual net profit margin is -479.18%

    Expenses

    Total Expenses

    $204.39M
    BCYC annual total expenses is $204.39 million

    Operating Expenses

    $280.58M
    BCYC annual total operating expenses is $280.58 million

    Cost Of Goods Sold

    $7.18M
    BCYC annual cost of goods sold is $7.18 million

    Selling, General & Administrative Expenses

    $0.00
    BCYC annual SG&A is $0.00

    Depreciation & Amortization

    $7.18M
    BCYC annual D&A is $7.18 million

    Interest Expense

    $0.00
    BCYC annual interest expense is $0.00

    Income Tax

    -$47.99M
    BCYC annual income tax is -$47.99 million

    EBIT & EBITDA

    EBIT

    -$252.47M
    BCYC annual earnings before interest & taxes is -$252.47 million

    EBITDA

    -$245.29M
    BCYC annual EBITDA is -$245.29 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $956.87M
    BCYC annual total assets is $956.87 million

    Non Current Assets

    $28.26M
    BCYC annual long term assets is $28.26 million

    Current Assets

    $928.61M
    BCYC annual total current assets is $928.61 million

    Cash and Cash Equivalents

    $879.52M
    BCYC annual cash & cash equivalents is $879.52 million

    Accounts Receivable

    $0.00
    BCYC annual accounts receivable is $0.00

    Inventory

    $0.00
    BCYC annual inventory is $0.00

    Liabilities

    Total Liabilities

    $163.81M
    BCYC annual total liabilities is $163.81 million

    Long Term Liabilities

    $96.58M
    BCYC annual total long term liabilities is $96.58 million

    Current Liabilities

    $67.23M
    BCYC annual current liabilities is $67.23 million

    Accounts Payable

    $15.79M
    BCYC annual accounts payable is $15.79 million

    Debt

    Total Debt

    $9.49M
    BCYC annual total debt is $9.49 million

    Total Debt 1-Year Change

    -78.88%
    BCYC annual total debt is down -78.88% year-on-year

    Long Term Debt

    $3.99M
    BCYC annual long term debt is $3.99 million

    Short Term Debt

    $5.50M
    BCYC annual short term debt is $5.50 million

    Equity & Capital

    Shareholders Equity

    $793.06M
    BCYC annual stockholders equity is $793.06 million

    Book Value

    $793.06M
    BCYC annual book value is $793.06 million

    Retained Earnings

    -$680.79M
    BCYC annual retained earnings is -$680.79 million

    Working Capital

    $861.38M
    BCYC annual working capital is $861.38 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$164.79M
    BCYC annual cash from operations is -$164.79 million

    Cash From Operations 1-Year Change

    -170.76%
    BCYC annual cash from operations is down -170.76% year-on-year

    Cash From Investing

    -$1.24M
    BCYC annual cash from investing is -$1.24 million

    Cash From Investing 1-Year Change

    +57.98%
    BCYC annual cash from investing is up +57.98% year-on-year

    Cash From Financing

    $519.97M
    BCYC annual cash from financing is $519.97 million

    Cash From Financing 1-Year Change

    +107.16%
    BCYC annual cash from financing is up +107.16% year-on-year

    CAPEX

    CAPEX

    $1.24M
    BCYC annual capital expenditures is $1.24 million

    CAPEX 1-Year Change

    -57.98%
    BCYC annual capital expenditures is down -57.98% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$166.03M
    BCYC annual free cash flow is -$166.03 million

    Free Cash Flow 1-Year Change

    -160.22%
    BCYC annual free cash flow is down -160.22% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    79.66%
    BCYC annual gross profit margin is 79.66%

    Operating Margin

    -715.41%
    BCYC annual operating profit margin is -715.41%

    Net Margin

    -479.18%
    BCYC annual net profit margin is -479.18%

    ROA & ROE

    ROA

    -21.79%
    BCYC annual return on assets is -21.79%

    ROE

    -29.06%
    BCYC annual return on equity is -29.06%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    BCYC price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    BCYC price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    1.11
    BCYC price to book ratio is 1.11

    PB Ratio Sector Percentile

    38.47%
    BCYC price to book ratio is higher than 38.47% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    17.50
    BCYC price to sales ratio is 17.50

    PS Ratio Sector Percentile

    79.08%
    BCYC price to sales ratio is higher than 79.08% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    -$146.56M
    BCYC enterprise value is -$146.56 million

    Enterprise Value Sector Percentile

    0.17%
    BCYC enterprise value is higher than 0.17% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    0.45
    BCYC EV/EBITDA is 0.45

    EV/EBITDA Sector Percentile

    69.05%
    BCYC EV/EBITDA is higher than 69.05% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    13.81
    BCYC annual current ratio is 13.81

    Quick Ratio

    13.81
    BCYC annual quick ratio is 13.81

    Leverage

    Debt To Equity

    0.01
    BCYC annual debt to equity ratio is 0.01

    Interest Coverage Ratio

    -
    BCYC annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    3
    BCYC piotroski f-score is 3

    Altman Z-Score

    1.06
    BCYC altman z-score is 1.06

    Analyst ratings

    Recent major analysts updates

    Oct 31, 25 RBC Capital
    Sector Perform
    Oct 31, 25 Citizens
    Market Outperform
    Aug 12, 25 Morgan Stanley
    Equal-Weight
    Aug 12, 25 JMP Securities
    Market Outperform
    Aug 11, 25 Oppenheimer
    Outperform
    Jul 17, 25 RBC Capital
    Outperform
    May 6, 25 Morgan Stanley
    Equal-Weight
    May 2, 25 RBC Capital
    Outperform
    May 2, 25 Needham
    Buy
    May 2, 25 JMP Securities
    Market Outperform

    Institutional Ownership

    Screeners with BCYC included

    Growing Shares Outstanding
    Stocks with high beta
    UK stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Bicycle Therapeutics plc?
    • Does Bicycle Therapeutics plc pay dividends?
    • What sector is Bicycle Therapeutics plc in?
    • What industry is Bicycle Therapeutics plc in?
    • What country is Bicycle Therapeutics plc based in?
    • When did Bicycle Therapeutics plc go public?
    • Is Bicycle Therapeutics plc in the S&P 500?
    • Is Bicycle Therapeutics plc in the NASDAQ 100?
    • Is Bicycle Therapeutics plc in the Dow Jones?
    • When was Bicycle Therapeutics plc's last earnings report?
    • When does Bicycle Therapeutics plc report earnings?

    What is the ticker symbol for Bicycle Therapeutics plc?

    The ticker symbol for Bicycle Therapeutics plc is NASDAQ:BCYC

    Does Bicycle Therapeutics plc pay dividends?

    No, Bicycle Therapeutics plc does not pay dividends

    What sector is Bicycle Therapeutics plc in?

    Bicycle Therapeutics plc is in the Healthcare sector

    What industry is Bicycle Therapeutics plc in?

    Bicycle Therapeutics plc is in the Biotechnology industry

    What country is Bicycle Therapeutics plc based in?

    Bicycle Therapeutics plc is headquartered in United Kingdom

    When did Bicycle Therapeutics plc go public?

    Bicycle Therapeutics plc's initial public offering (IPO) was on May 23, 2019

    Is Bicycle Therapeutics plc in the S&P 500?

    No, Bicycle Therapeutics plc is not included in the S&P 500 index

    Is Bicycle Therapeutics plc in the NASDAQ 100?

    No, Bicycle Therapeutics plc is not included in the NASDAQ 100 index

    Is Bicycle Therapeutics plc in the Dow Jones?

    No, Bicycle Therapeutics plc is not included in the Dow Jones index

    When was Bicycle Therapeutics plc's last earnings report?

    Bicycle Therapeutics plc's most recent earnings report was on October 30, 2025

    When does Bicycle Therapeutics plc report earnings?

    The next expected earnings date for Bicycle Therapeutics plc is February 24, 2026
    On this page